SBIR Phase I: Biofeedback system for adults with Parkinson’s disease

SBIR 第一阶段：针对帕金森病成人的生物反馈系统

• 批准号: 2136439
• 负责人: Daniel Furman
• 金额: $ 25.58万
• 依托单位: QUADRALYNX, INC
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-12-15 至 2022-07-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=2136439&HistoricalAwards=false
• 关键词: SBIR; Phase; Biofeedback; system; adults

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is a wearable device and associated software that will decrease the cost of care and improve the quality of life of the 1+ M patients with Parkinson’s disease, their personal caregivers, and their medical providers. This project will increase our understanding of Parkinson’s disease and other neurological and motor disorders. It will reduce current costly treatments with an online solution using the device and associated software. The research objective is to develop the hardware, software application, and database that constitute a complete, working system which will improve the quality of life for Parkinson’s patients and improve the data available for Parkinson’s disease researchers.This Small Business Innovation Research (SBIR) Phase I project will develop a wearable biomedical feedback device that communicates with a mobile application to alert users in real time when a specific physical vocal pathology is detected by the device. Post-event information can then be evaluated by users and their medical caregivers using a graphical user interface within the mobile application. Data will also be transmitted and stored in a database of people with Parkinson’s disease. Upon addition and refinement of new data, the technical results will include a wearable device, analytic software, and a database will be used to improve and fine-tune the software to improve both the identification, speed, and modality of correction as well as serve a highly valuable database for Parkinson’s researchers.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

这个小型企业创新研究(SBIR)第一阶段项目的更广泛的影响/商业潜力是一种可穿戴设备和相关软件，它将降低护理成本，并改善1+M帕金森氏症患者、他们的个人护理人员和他们的医疗提供者的生活质量。这个项目将增加我们对帕金森氏症以及其他神经和运动障碍的了解。通过使用该设备和相关软件的在线解决方案，它将减少目前昂贵的治疗。该研究的目标是开发硬件、软件应用程序和数据库，以构成一个完整的工作系统，以提高帕金森患者的生活质量，并改善帕金森病研究人员可用的数据。这个小型企业创新研究(SBIR)第一阶段项目将开发一种可穿戴的生物医学反馈设备，该设备将与移动应用程序通信，当该设备检测到特定的物理嗓音病理时，实时提醒用户。然后，用户和他们的医疗护理人员可以使用移动应用程序内的图形用户界面来评估事件后信息。数据还将被传输并存储在帕金森氏症患者的数据库中。在添加和提炼新数据后，技术成果将包括可穿戴设备、分析软件和数据库，将用于改进和微调软件，以提高识别、速度和纠正方式，并为帕金森氏症研究人员提供一个非常有价值的数据库。该奖项反映了NSF的法定使命，并通过使用基金会的智力优势和更广泛的影响审查标准进行评估，被认为值得支持。